Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

Virtual Meeting to be held on February 20 hosted by BTIG.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...

DexCom Q4 revenue rose 8% YoY to $1.11 billion, beating estimates of $1.104 billion. DexCom reaffirms 2025 revenue guidance at $4.60 billion vs. consensus of $4.61 billion. Get access to your new ...

DexCom Inc. closed 39.17% below its 52-week high of $142.00, which the company reached on March 26th.

Operating income (non-GAAP) decreased to $209.5 million from $242.7 million. DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. DexCom ...

Shares of DexCom Inc. DXCM slid 2.91% to $83.87 Wednesday, on what proved to be an all-around poor trading session for the ...

My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Dexcom Inc. fourth quarter 2024 earnings release conference call. All lines ...

DexCom (NASDAQ:DXCM), known for its continuous glucose monitoring (CGM) systems, recently unveiled its Q4 2024 earnings report on Feb. 13, 2025. This release highlighted an 8% growth in revenue ...

At this time, I would like to welcome everyone to the Dexcom Inc. fourth quarter 2024 earnings release conference call. All lines have been placed on mute to prevent any background noise. After the ...

Financial giants have made a conspicuous bearish move on DexCom. Our analysis of options history for DexCom (NASDAQ:DXCM) revealed 12 unusual trades. Delving into the details, we found 33% of ...

Management believes organic revenue is a meaningful metric to investors as it provides a more consistent comparison of Dexcom’s revenue to prior periods as well as to industry peers. We exclude ...